CTOs on the Move

Impact Advisors

www.impact-advisors.com

 
Impact Advisors is a nationally recognized healthcare consulting firm that is solving some of the toughest challenges in the industry by delivering strategic advisory, implementation and optimization services. Our comprehensive suite of patient access, clinical and revenue cycle services span the lifecycle of our clients` needs. Our experienced team has a powerful combination of clinical, revenue, operations, consulting, and IT experience. The firm has earned a number of prestigious industry and workplace awards including Best in KLAS® for thirteen consecutive years, Healthcare Informatics HCI 100, Crain`s Chicago Business Fast Fifty, as well as multi-year “best place to work” awards from: ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Michael Doyle
 Vice President of Information Technology Advisory Enterprise Analytics Profile
Marc Johnson
 Senior Advisor / vCISO / vCIO Profile

Similar Companies

The American Journal of Pharmacy Benefits

The American Journal of Pharmacy Benefits is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Virtual Medical Sales

Virtual Medical Sales is a East Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fluortek

Fluortek is a Easton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Apollo Medical

ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Advanced MR Analytics

AMRA is the first in the world to transform images from a 6-minute whole body MRI scan into precise, 3D-volumetric, geographical fat and muscle measurements. Our aim is to redefine obesity and metabolic risk through precision medicine - understanding the interplay between fat, muscle and the development of metabolic disease.